SUNESIS PHARMACEUTI (NASDAQ:SNSS)
0.31
-0 (-0%)
| SUNESIS PHARMACEUTI (NASDAQ:SNSS) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $0.31 | 52 Week High | $1.00 | ||
| Open | $0.30 | 52 Week Low | $0.05 | ||
| Day High | $0.32 | P/E | N/A | ||
| Day Low | $0.28 | EPS | $-2.01 | ||
| Volume | 402,170 | ||||
| More SNSS Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| GS | 1 | HBAN | 1 |
| JASO | 1 | OSIP | 1 |
| GSK | 1 | PBH | 1 |
| SNBP | 1 | SNTA | 1 |
| BIIB | 1 | BAC | 1 |
| CYTR | 1 | ||
Entities who have mentioned SNSS
- 13D | View Related Stories »
- Warburg Pincus | View Related Stories »
- 13G | View Related Stories »
- Rodman & Renshaw | View Related Stories »
- Banc of America | View Related Stories »
- Caxton Associates | View Related Stories »
- New Enterprise Associates | View Related Stories »
- Lazard | View Related Stories »
- Twitter | View Related Stories »
- Collins Stewart | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Piper Jaffray | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
View All ReportsStreetInsider.com Reports on SNSS
- SNSS, CYTR, OSIP, HBAN, JASO, BAC, GS See Volume and Upside Price Action
- Sunesis Pharmaceuticals (SNSS) Receives $1.5M Milestone Payment From Biogen Idec (BIIB)
- Rodman & Renshaw Downgrades Sunesis Pharmaceuticals (SNSS) to Market Perform
View All Press ReleasesCompany Press Releases on SNSS
- Trading Overview for Sinobiopharma Inc. Issued by StockPreacher.com
- Sunesis Reports Data From Nonclinical Studies of Voreloxin at AACR-EORTC-NCI Conference
- Sunesis Reports Financial Results for the Third Quarter of 2009
- Sunesis to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Sunesis to Present Nonclinical Voreloxin Combination Data at AACR-EORTC-NCI Conference
StreetInsider Reports on SNSS by Category
View All BlogsBlogs on SNSS
- Closing Update for Monday, June 13
- Sunesis: Publish or Perish?
- Top Pre-Market Analyst Upgrades (ALK, AMR, AAPL, CAL, DAL, DELL, JPM, LDK, PENN, SCR, SNSS, LCC)
View All FilingsSEC Filings on SNSS
- Form 8-K SUNESIS PHARMACEUTICALS For: Nov 16
- Form SC 13D SUNESIS PHARMACEUTICALS Filed by: Growth Equity Opportunities Fund, LLC
- Form 10-Q SUNESIS PHARMACEUTICALS For: Sep 30
- Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: VISION CAPITAL ADVISORS, LLC
- Form SC 13D/A WARBURG PINCUS EQUITY
Comments on recent SNSS articles
Comments on SNSS
No comments are currently available.
on Feb 20, 2008
at 03:42 PM INSM A $3.00 dollar stock trading below a $1.00.
Article: Analyst Call of the Year: Collins Stewart on Encysive (ENCY)